Last 40 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.01 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.40 | 6.15 | 2.32 | 7.00 | 9.54 | 7.94 | 163.45 | 179.98 | — | 1710.60 | 11015.05 | 27156.95 | — |
| — | -22.5% | -98.6% | -96.1% | — | -99.5% | -98.5% | -99.3% | — | -97.4% | -82.5% | -88.3% | — | |
| P/B Ratio | 0.01 | 7.39 | 6.58 | 13.74 | 5.05 | — | 880.64 | 111742.89 | — | 17893.26 | — | 427345.35 | — |
| — | — | -99.3% | -100.0% | — | — | — | -73.9% | — | -62.4% | — | +1480.2% | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
INVO Fertility, Inc.'s operating margin was -93.1% in Q3 2025, up 67.4 pp QoQ and down 2.3 pp YoY. This marks the 3rd consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of -383.6% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin expanded 15.4% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.0% | 35.8% | 41.3% | 36.2% | 43.2% | 31.0% | 53.1% | 46.1% | 35.8% | 40.4% | 19.1% | 60.3% | 47.9% |
| — | +15.4% | -22.2% | -21.5% | +20.6% | -23.2% | +177.3% | -23.6% | -25.1% | +56.8% | +970.8% | +200.5% | -50.3% | |
| Operating Margin | -124.4% | -93.1% | -160.4% | -1044.9% | -235.8% | -90.7% | -103.6% | -60.0% | -109.2% | -90.9% | -654.0% | -662.7% | -977.3% |
| — | -2.6% | -54.9% | -1640.4% | -116.0% | +0.2% | +84.2% | +90.9% | +88.8% | +91.5% | +64.4% | +60.1% | -6016.1% | |
| Net Margin | -139.3% | -150.5% | -283.6% | -1063.0% | -214.9% | -113.8% | -122.2% | -101.3% | -144.4% | -128.1% | -709.2% | -733.0% | -994.8% |
| — | -32.3% | -132.0% | -949.6% | -48.9% | +11.1% | +82.8% | +86.2% | +85.5% | +88.2% | +63.0% | +57.0% | -21327.3% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -133.4% | -62.4% | -177.1% | -216.4% | -57.0% | -243.3% | -326.9% | -353.6% | -315.2% | -334.9% | — | -2883.5% | -1787.4% |
| — | +74.4% | +45.8% | +38.8% | +81.9% | +27.3% | — | +87.7% | +82.4% | -205.0% | — | -6604.1% | -60943.7% | |
| ROA | -28.0% | -13.9% | -20.7% | -44.5% | -11.4% | -9.3% | -12.4% | -8.7% | -10.5% | -9.6% | -35.0% | -49.7% | -63.0% |
| — | -49.0% | -67.6% | -413.4% | -8.7% | +2.7% | +64.7% | +82.6% | +83.3% | +79.2% | +6.6% | -70.2% | -4043.6% | |
| ROIC | -42.2% | -13.0% | -21.8% | -77.2% | -22.3% | -18.3% | -24.4% | -11.0% | -15.0% | -11.6% | -74.4% | -141.6% | -89.5% |
| — | +29.3% | +10.4% | -600.4% | -48.7% | -57.8% | +67.3% | +92.2% | +83.2% | +80.5% | -33.8% | -164.6% | -475.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has weakened 45.6% YoY to 0.12x, tightening the short-term liquidity position.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.78 | 0.72 | 2.71 | 2.65 | 0.78 | — | 3.94 | 628.25 | 7.06 | 23.62 | — | 33.30 | — |
| — | — | -31.3% | -99.6% | -89.0% | — | — | +1786.5% | — | +1452.8% | — | +8897.0% | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.07 | 0.12 | 0.11 | 0.08 | 0.07 | 0.23 | 0.30 | 0.19 | 0.16 | 0.37 | 0.19 | 0.63 | 0.18 |
| — | -45.6% | -62.6% | -56.5% | -53.3% | -38.4% | +59.2% | -69.5% | -13.6% | -35.3% | -90.5% | -84.5% | -96.4% | |
| Quick Ratio | 0.06 | 0.10 | 0.10 | 0.07 | 0.06 | 0.20 | 0.27 | 0.16 | 0.12 | 0.31 | 0.13 | 0.57 | 0.10 |
| — | -48.4% | -64.6% | -55.6% | -50.7% | -37.0% | +113.6% | -71.5% | +18.6% | -21.0% | -92.9% | -85.0% | -97.8% | |
| Interest Coverage | -7.63 | -11.22 | -13.50 | -54.91 | -14.86 | -4.85 | -5.07 | -7.80 | -9.83 | -2.54 | -11.77 | -10.78 | -48.26 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 40 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying IVF stock.
INVO Fertility, Inc.'s current P/E is -0.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
INVO Fertility, Inc.'s current operating margin is -124.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking INVO Fertility, Inc.'s business trajectory between earnings reports.